GlassScriptPhysician profile
Candace Danielle Thomas
NPI 1023534401
$3,468.85
in general payments reported to CMS, 2019-2025
21 companies · $526 in 2025
The $526 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $650 · 2022: $727 · 2023: $630 · 2024: $936 · 2025: $526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,619 · Education: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,619.18 |
| Education | $472.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $799.34 | 2021-2024 | Tremfya |
| Sun Pharmaceutical Industries INC. | $700.07 | 2021-2025 | |
| Abbvie INC. | $375.70 | 2023-2025 | |
| Ucb, INC. | $183.68 | 2025 | Bimzelx |
| Verrica Pharmaceuticals INC. | $166.90 | 2023-2024 | Ycanth |
| Allergan, INC. | $148.65 | 2021-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $126.59 | 2021 | |
| Janssen Scientific Affairs, LLC | $124.46 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $119.79 | 2022 | |
| Lilly USA, LLC | $111.38 | 2021-2023 | Olumiant, Taltz |
| Genzyme Corporation | $107.23 | 2021-2024 | |
| Dermavant Sciences, INC. | $82.04 | 2023 | Vtama |
| Pfizer INC. | $71.39 | 2021-2022 | |
| Boston Scientific Corporation | $64.95 | 2022 | |
| Novartis Pharmaceuticals Corporation | $64.33 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $58.73 | 2023-2024 | Sotyktu |
| Almirall LLC | $58.56 | 2022 | |
| Incyte Corporation | $54.40 | 2021 | |
| Biofrontera INC. | $18.95 | 2022 | |
| Arcutis Biotherapeutics, INC. | $18.50 | 2024 | Zoryve |
| Galderma Laboratories, L.P. | $13.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candace Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.